Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB-IV NSCLC (LCDigital-IO Study): a multicenter retrospective study.
Wu S, Zhan W, Liu L, Xie D, Yao L, Yao H, Liao G, Huang L, Zhou Y, You P, Huang Z, Li Q, Xu B, Wang S, Wang G, Zhang DK, Qiao G, Chan LW, Lanuti M, Zhou H.
Wu S, et al. Among authors: zhang dk.
J Immunother Cancer. 2023 Oct;11(10):e007369. doi: 10.1136/jitc-2023-007369.
J Immunother Cancer. 2023.
PMID: 37865396
Free PMC article.